A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations
Completed
Peplin
Phase 3
2008-09-01
The purpose of this study is to determine whether topical application of PEP005 is effective
for the treatment of actinic keratoses.
A Study to Evaluate the Pharmacokinetics of PEP005 (Ingenol Mebutate) Gel, 0.05%, When Applied in a Maximal Use Setting to the Dorsal Aspect of the Forearm in Patients With Actinic Keratosis
Completed
Peplin
Phase 2
2009-03-01
This Phase II study is designed to evaluate the pharmacokinetics of PEP005 (ingenol mebutate)
Gel, 0.05% when applied in a maximal use setting to the dorsal aspect of the forearm in
patients with actinic keratoses
A Multi-Center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)
Completed
Peplin
Phase 3
2009-06-01
This Phase III study is designed to assess the efficacy and safety of PEP005 Gel, 0.015% when
applied to an area of skin containing 4-8 AK lesions on the face or scalp.
A Multi-center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)
Completed
Peplin
Phase 3
2009-06-01
This Phase III study is designed to assess the efficacy and safety of PEP005 Gel, 0.015% when
applied to an area of skin containing 4-8 AK lesions on the face or scalp.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
